News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Volatile AstraZeneca Pharma India Ltd. (AZN) Rallies On Delisting Plans


3/14/2014 8:00:03 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AstraZeneca Pharma India Ltd’s board will meet on 15 March to decide on delisting the company’s shares from the stock exchanges. The drug maker’s Swedish parent, AstraZeneca Pharmaceuticals AB, had on 1 March written to the Indian unit about its decision to voluntarily delist the company. AstraZeneca India’s board met on 5 March to consider the proposal but informed the stock exchanges that it had decided to defer the delisting plan and seek more details on it from the parent company.

Help employers find you! Check out all the jobs and post your resume.

Read at Live Mint
Read at Business Standard
Read at India Times
Read at NDTV.com
Read at myiris


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES